Steroid Powder Flibanserin USA Raws

Steroid Powder Flibanserin USA
Steroid Powder Flibanserin USA
  • Model: Steroids-078
  • 500 Kilogram in Stock

Company Name: Shanghai MeiHua

Certification: ISO9001, SGS, KOSHER

Delivery Time: 5~8 working days

Delivery Way: Domestic Delivery in Canada, Europe

Payment Terms: T/T, Western Union, MoneyGram, Bitcoin


WhatsApp: +8617612057092

Contact US


Buy Pharmaceutical Sex Raw Flibanserin Powder for Female Sexual Desire

Product Name:

Flibanserin Powder

CAS No.:


Molecular Formula:




Price Term:

Western Union, Money Gram, Bank Transfer, BTC

Domestic MOQ:




Delivery time:

According to the custom pass rate




What Is Flibanserin? How Does It Work?


Flibanserin is a drug used to treat hyposexual desire disorder (HSDD) in women. Women with HSDD have a chronic lack of interest in sex that cannot be explained by another disease. HSDD is accompanied by painful feelings.

Sometimes Flibanserin is called "female viagra," but that term isn't quite accurate. Viagra is a drug used to treat men with erectile dysfunction that improves blood flow to the penis. In other words, it mainly affects the genitals. Flibanserin is different because it ACTS on the female brain.

The brain is often considered the more important sex organ for women. Much of her sexual response cycle originates in the brain.

Flibanserin ACTS on three important brain chemicals: dopamine, norepinephrine and serotonin. These chemicals are neurotransmitters. They are responsible for sending signals through the nervous system between the brain and the rest of the body.

Dopamine and norepinephrine are associated with sexual arousal. Serotonin, however, contributes to sexual inhibition and may inhibit libido. It is thought that if these chemicals are out of whack - if dopamine and norepinephrine levels are too low and/or serotonin levels are too high - a woman's sex drive may be reduced.


Effect of Flibanserin


The effect of Flibanserin is to increase dopamine and norepinephrine levels while lowering serotonin levels. In this way, there are more libido-promoting chemicals and fewer libido-suppressing chemicals.

Flibanserin is a pill you take once a day before bed.


Studies On Flibanserin


Flibanserin is an approved treatment for premenopausal women with hypoactive sexual desire disorder (HSDD). From the first two to three months, the drug increases sexual satisfaction by about half a month compared with a placebo. The certainty of this estimate is very low. Side effects of dizziness, drowsiness and nausea are three to four times more common.

Flibanserin is a new drug being developed to prevent HSDD in women. HSDD is a relatively new term for a disorder called hyposexual desire disorder, which basically refers to low sexual desire, or low sexual desire, in healthy women. Studies show that about 10 to 20 percent of women face this problem, and some say there are more women with HSDD than men. Flibanserin can be divided into 5-hydroxytryptamine receptor agonist and dopamine D4 receptor partial agonist. It's a non-hormonal substance that essentially increases dopamine and norepinephrine while decreasing serotonin in the brain. In return, it seems to have a positive effect on a woman's libido, which is otherwise lacking. The advantage of non-hormonal therapy is that it does not cause other hormone-related problems, such as negative emotions and other problems.

Flibanserin is used in women with low sexual desire. Patients treated with Flibanserin reported a 0.5 increase in the number of "satisfying sexual encounters" compared with placebo. The number of placebos per month increased from 2.8 to 4.5 for women on Flibanserin, and from 2.7 to 3.7 for women on placebo. Flibanserin appeared at the first time point measured four weeks after treatment and was maintained throughout the treatment.

To evaluate the efficacy of Flibanserin in a phase iii clinical trial. All three trials had two primary ends in common, the satisfying sexual SSEs and the libido. Each of the three trials had a secondary endpoint for measuring pain associated with libido. All three trials showed that Flibanserin increased the number of tosses and reduced the pain associated with sexual desire. The first two experiments used electronic diaries to measure libido and found no increase. Both trials also used the female sexual function index (FSFI) as a secondary endpoint to measure libido, and observed increases in libido using the latter measure. In the third trial, FSFI was used as a common primary endpoint for libido and again showed a statistically significant increase.